The PDA Midwest Chapter is pleased to present a great topic for our December 2020 event to focus on recent FDA 483 observations and corrective actions. Special considerations will be given to how these observations and regulations relate to USP 797 and GMPs. Please join us for a live presentation including a Q&A session with our experienced industry expert.
Seth DePasquale, an experienced and certified compounding pharmacist licensed in numerous states and co-founder of LyceumCE.com. He also works with the American Pharmacists Association as a Director of Content Creation. His practicing pharmacist experience spans from the US Air Force to CVS to Veterinary compounding.